Global Panitumumab Market 2021 by Company, Regions, Type and Application, Forecast to 2026

June 2021 | 105 pages | ID: GC3434948ADEN
GlobalInfoResearch

Abstracts

The Panitumumab market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Panitumumab size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Panitumumab market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Panitumumab market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

• 100 mg/5 mL single-dose vials
• 400 mg/20 mLsingle-dose vials

Market segment by Application, can be divided into

• Hospital
• Drug store

Market segment by players, this report covers

• Amgen

Market segment by regions, regional analysis covers

• North America (United States, Canada, and Mexico)
• Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
• South America (Brazil, Argentina, Rest of South America)
• Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Contents

1 MARKET OVERVIEW

1.1 Product Overview and Scope of Panitumumab
1.2 Classification of Panitumumab by Type
  1.2.1 Overview: Global Panitumumab Market Size by Type: 2020 Versus 2021 Versus 2026
  1.2.2 Global Panitumumab Revenue Market Share by Type in 2020
  1.2.3 100 mg/5 mL single-dose vials
  1.2.4 400 mg/20 mLsingle-dose vials
1.3 Global Panitumumab Market by Application
  1.3.1 Overview: Global Panitumumab Market Size by Application: 2020 Versus 2021 Versus 2026
  1.3.2 Hospital
  1.3.3 Drug store
1.4 Global Panitumumab Market Size & Forecast
1.5 Global Panitumumab Market Size and Forecast by Region
  1.5.1 Global Panitumumab Market Size by Region: 2016 VS 2021 VS 2026
  1.5.2 Global Panitumumab Market Size by Region, (2016-2021)
  1.5.3 North America Panitumumab Market Size and Prospect (2016-2026)
  1.5.4 Europe Panitumumab Market Size and Prospect (2016-2026)
  1.5.5 Asia-Pacific Panitumumab Market Size and Prospect (2016-2026)
  1.5.6 South America Panitumumab Market Size and Prospect (2016-2026)
  1.5.7 Middle East and Africa Panitumumab Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
  1.6.1 Panitumumab Market Drivers
  1.6.2 Panitumumab Market Restraints
  1.6.3 Panitumumab Trends Analysis

2 COMPANY PROFILES

2.1 Amgen
  2.1.1 Amgen Details
  2.1.2 Amgen Major Business
  2.1.3 Amgen Panitumumab Product and Solutions
  2.1.4 Amgen Panitumumab Revenue, Gross Margin and Market Share (2019-2021)
  2.1.5 Amgen Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Panitumumab Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
  3.2.1 Top 3 Panitumumab Players Market Share
  3.2.2 Top 10 Panitumumab Players Market Share
  3.2.3 Market Competition Trend
3.3 Panitumumab Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans

4 MARKET SIZE SEGMENT BY TYPE

4.1 Global Panitumumab Revenue and Market Share by Type (2016-2021)
4.2 Global Panitumumab Market Forecast by Type (2021-2026)

5 MARKET SIZE SEGMENT BY APPLICATION

5.1 Global Panitumumab Revenue Market Share by Application (2016-2021)
5.2 Panitumumab Market Forecast by Application (2021-2026)

6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION

6.1 North America Panitumumab Revenue by Type (2016-2026)
6.2 North America Panitumumab Revenue by Application (2016-2026)
6.3 North America Panitumumab Market Size by Country
  6.3.1 North America Panitumumab Revenue by Country (2016-2026)
  6.3.2 United States Panitumumab Market Size and Forecast (2016-2026)
  6.3.3 Canada Panitumumab Market Size and Forecast (2016-2026)
  6.3.4 Mexico Panitumumab Market Size and Forecast (2016-2026)

7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION

7.1 Europe Panitumumab Revenue by Type (2016-2026)
7.2 Europe Panitumumab Revenue by Application (2016-2026)
7.3 Europe Panitumumab Market Size by Country
  7.3.1 Europe Panitumumab Revenue by Country (2016-2026)
  7.3.2 Germany Panitumumab Market Size and Forecast (2016-2026)
  7.3.3 France Panitumumab Market Size and Forecast (2016-2026)
  7.3.4 United Kingdom Panitumumab Market Size and Forecast (2016-2026)
  7.3.5 Russia Panitumumab Market Size and Forecast (2016-2026)
  7.3.6 Italy Panitumumab Market Size and Forecast (2016-2026)

8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION

8.1 Asia-Pacific Panitumumab Revenue by Type (2016-2026)
8.2 Asia-Pacific Panitumumab Revenue by Application (2016-2026)
8.3 Asia-Pacific Panitumumab Market Size by Region
  8.3.1 Asia-Pacific Panitumumab Revenue by Region (2016-2026)
  8.3.2 China Panitumumab Market Size and Forecast (2016-2026)
  8.3.3 Japan Panitumumab Market Size and Forecast (2016-2026)
  8.3.4 South Korea Panitumumab Market Size and Forecast (2016-2026)
  8.3.5 India Panitumumab Market Size and Forecast (2016-2026)
  8.3.6 Southeast Asia Panitumumab Market Size and Forecast (2016-2026)
  8.3.7 Australia Panitumumab Market Size and Forecast (2016-2026)

9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION

9.1 South America Panitumumab Revenue by Type (2016-2026)
9.2 South America Panitumumab Revenue by Application (2016-2026)
9.3 South America Panitumumab Market Size by Country
  9.3.1 South America Panitumumab Revenue by Country (2016-2026)
  9.3.2 Brazil Panitumumab Market Size and Forecast (2016-2026)
  9.3.3 Argentina Panitumumab Market Size and Forecast (2016-2026)

10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION

10.1 Middle East & Africa Panitumumab Revenue by Type (2016-2026)
10.2 Middle East & Africa Panitumumab Revenue by Application (2016-2026)
10.3 Middle East & Africa Panitumumab Market Size by Country
  10.3.1 Middle East & Africa Panitumumab Revenue by Country (2016-2026)
  10.3.2 Turkey Panitumumab Market Size and Forecast (2016-2026)
  10.3.3 Saudi Arabia Panitumumab Market Size and Forecast (2016-2026)
  10.3.4 UAE Panitumumab Market Size and Forecast (2016-2026)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Global Panitumumab Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Panitumumab Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Panitumumab Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Panitumumab Revenue (USD Million) by Region (2016-2021)
Table 5. Global Panitumumab Revenue Market Share by Region (2021-2026)
Table 6. Amgen Corporate Information, Head Office, and Major Competitors
Table 7. Amgen Major Business
Table 8. Amgen Panitumumab Product and Solutions
Table 9. Amgen Panitumumab Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Global Panitumumab Revenue (USD Million) by Players (2019-2021)
Table 11. Global Panitumumab Revenue Share by Players (2019-2021)
Table 12. Breakdown of Panitumumab by Company Type (Tier 1, Tier 2 and Tier 3)
Table 13. Panitumumab Players Head Office, Products and Services Provided
Table 14. Panitumumab Mergers & Acquisitions in the Past Five Years
Table 15. Panitumumab New Entrants and Expansion Plans
Table 16. Global Panitumumab Revenue (USD Million) by Type (2016-2021)
Table 17. Global Panitumumab Revenue Share by Type (2016-2021)
Table 18. Global Panitumumab Revenue Forecast by Type (2021-2026)
Table 19. Global Panitumumab Revenue by Application (2016-2021)
Table 20. Global Panitumumab Revenue Forecast by Application (2021-2026)
Table 21. North America Panitumumab Revenue by Type (2016-2021) & (USD Million)
Table 22. North America Panitumumab Revenue by Type (2021-2026) & (USD Million)
Table 23. North America Panitumumab Revenue by Application (2016-2021) & (USD Million)
Table 24. North America Panitumumab Revenue by Application (2021-2026) & (USD Million)
Table 25. North America Panitumumab Revenue by Country (2016-2021) & (USD Million)
Table 26. North America Panitumumab Revenue by Country (2021-2026) & (USD Million)
Table 27. Europe Panitumumab Revenue by Type (2016-2021) & (USD Million)
Table 28. Europe Panitumumab Revenue by Type (2021-2026) & (USD Million)
Table 29. Europe Panitumumab Revenue by Application (2016-2021) & (USD Million)
Table 30. Europe Panitumumab Revenue by Application (2021-2026) & (USD Million)
Table 31. Europe Panitumumab Revenue by Country (2016-2021) & (USD Million)
Table 32. Europe Panitumumab Revenue by Country (2021-2026) & (USD Million)
Table 33. Asia-Pacific Panitumumab Revenue by Type (2016-2021) & (USD Million)
Table 34. Asia-Pacific Panitumumab Revenue by Type (2021-2026) & (USD Million)
Table 35. Asia-Pacific Panitumumab Revenue by Application (2016-2021) & (USD Million)
Table 36. Asia-Pacific Panitumumab Revenue by Application (2021-2026) & (USD Million)
Table 37. Asia-Pacific Panitumumab Revenue by Region (2016-2021) & (USD Million)
Table 38. Asia-Pacific Panitumumab Revenue by Region (2021-2026) & (USD Million)
Table 39. South America Panitumumab Revenue by Type (2016-2021) & (USD Million)
Table 40. South America Panitumumab Revenue by Type (2021-2026) & (USD Million)
Table 41. South America Panitumumab Revenue by Application (2016-2021) & (USD Million)
Table 42. South America Panitumumab Revenue by Application (2021-2026) & (USD Million)
Table 43. South America Panitumumab Revenue by Country (2016-2021) & (USD Million)
Table 44. South America Panitumumab Revenue by Country (2021-2026) & (USD Million)
Table 45. Middle East & Africa Panitumumab Revenue by Type (2016-2021) & (USD Million)
Table 46. Middle East & Africa Panitumumab Revenue by Type (2021-2026) & (USD Million)
Table 47. Middle East & Africa Panitumumab Revenue by Application (2016-2021) & (USD Million)
Table 48. Middle East & Africa Panitumumab Revenue by Application (2021-2026) & (USD Million)
Table 49. Middle East & Africa Panitumumab Revenue by Country (2016-2021) & (USD Million)
Table 50. Middle East & Africa Panitumumab Revenue by Country (2021-2026) & (USD Million)

List Of Figures

LIST OF FIGURES

Figure 1. Panitumumab Picture
Figure 2. Global Panitumumab Revenue Market Share by Type in 2020
Figure 3. 100 mg/5 mL single-dose vials
Figure 4. 400 mg/20 mLsingle-dose vials
Figure 5. Panitumumab Revenue Market Share by Application in 2020
Figure 6. Hospital Picture
Figure 7. Drug store Picture
Figure 8. Global Panitumumab Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 9. Global Panitumumab Revenue and Forecast (2016-2026) & (USD Million)
Figure 10. Global Panitumumab Revenue Market Share by Region (2016-2026)
Figure 11. Global Panitumumab Revenue Market Share by Region in 2020
Figure 12. North America Panitumumab Revenue (USD Million) and Growth Rate (2016-2026)
Figure 13. Europe Panitumumab Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Asia-Pacific Panitumumab Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. South America Panitumumab Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Middle East and Africa Panitumumab Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Panitumumab Market Drivers
Figure 18. Panitumumab Market Restraints
Figure 19. Panitumumab Market Trends
Figure 20. Amgen Recent Developments and Future Plans
Figure 21. Global Panitumumab Revenue Share by Players in 2020
Figure 22. Panitumumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 23. Global Top 3 Players Panitumumab Revenue Market Share in 2020
Figure 24. Global Top 10 Players Panitumumab Revenue Market Share in 2020
Figure 25. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 26. Global Panitumumab Revenue Share by Type in 2020
Figure 27. Global Panitumumab Market Share Forecast by Type (2021-2026)
Figure 28. Global Panitumumab Revenue Share by Application in 2020
Figure 29. Global Panitumumab Market Share Forecast by Application (2021-2026)
Figure 30. North America Panitumumab Sales Market Share by Type (2016-2026)
Figure 31. North America Panitumumab Sales Market Share by Application (2016-2026)
Figure 32. North America Panitumumab Revenue Market Share by Country (2016-2026)
Figure 33. United States Panitumumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Canada Panitumumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. Mexico Panitumumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 36. Europe Panitumumab Sales Market Share by Type (2016-2026)
Figure 37. Europe Panitumumab Sales Market Share by Application (2016-2026)
Figure 38. Europe Panitumumab Revenue Market Share by Country (2016-2026)
Figure 39. Germany Panitumumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. France Panitumumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. United Kingdom Panitumumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Russia Panitumumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Italy Panitumumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Asia-Pacific Panitumumab Sales Market Share by Type (2016-2026)
Figure 45. Asia-Pacific Panitumumab Sales Market Share by Application (2016-2026)
Figure 46. Asia-Pacific Panitumumab Revenue Market Share by Region (2016-2026)
Figure 47. China Panitumumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Japan Panitumumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. South Korea Panitumumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. India Panitumumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Southeast Asia Panitumumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Australia Panitumumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. South America Panitumumab Sales Market Share by Type (2016-2026)
Figure 54. South America Panitumumab Sales Market Share by Application (2016-2026)
Figure 55. South America Panitumumab Revenue Market Share by Country (2016-2026)
Figure 56. Brazil Panitumumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Argentina Panitumumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Middle East and Africa Panitumumab Sales Market Share by Type (2016-2026)
Figure 59. Middle East and Africa Panitumumab Sales Market Share by Application (2016-2026)
Figure 60. Middle East and Africa Panitumumab Revenue Market Share by Country (2016-2026)
Figure 61. Turkey Panitumumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Saudi Arabia Panitumumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. UAE Panitumumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Methodology
Figure 65. Research Process and Data Source